Browse studies
Find your next paid study
64 recruiting studies matching your filters
Phase 3
Cognitive Training to Reduce Incidence of Cognitive Impairment in Older Adults
Dementia is the most expensive medical condition in the US and increases in prevalence with age. More than 5 million Americans have Alzheimer's disease, the mo…
Age-related Cognitive DeclineAlzheimer's Disease and Related Dementias
Estimated
~$10 – $6,250
University of South FloridaNCT03848312
Phase 1
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
The overall objective is to obtain an assessment of the pharmacokinetics of \[18F\]3F4AP in healthy volunteers and subjects with demyelinating diseases such as…
Demyelinating DisordersMCIAlzheimer's Disease (AD)+3 more
Estimated
~$10 – $6,250
Yale UniversityNCT06999434
Observational
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after…
Critical IllnessDeliriumCognitive Impairment+5 more
Estimated
~$10 – $6,250
University of WashingtonNCT06411561
Phase 2
A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
This study is a Phase 2b/3 clinical trial of a new candidate drug (T3D-959) to treat patients with mild-to-moderate Alzheimer's. The aims of the trial are to a…
Alzheimer's Disease
Estimated
~$10 – $8,750
T3D Therapeutics, Inc.NCT06964230